Get the Stockscreener App
26.63
3.82%
0.98
After Hours:
26.66
0.03
+0.11%
Progyny Inc stock is traded at $26.63, with a volume of 1.31M.
It is up +3.82% in the last 24 hours and up +13.56% over the past month.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$25.65
Open:
$25.65
24h Volume:
1.31M
Relative Volume:
0.89
Market Cap:
$2.09B
Revenue:
$1.29B
Net Income/Loss:
$67.69M
P/E Ratio:
34.58
EPS:
0.7701
Net Cash Flow:
$184.42M
1W Performance:
+2.98%
1M Performance:
+13.56%
6M Performance:
-0.30%
1Y Performance:
+23.57%
1-Day Range:
$25.18
$26.74
1-Week Range:
$25.18
$26.74
52-Week Range:
$16.10
$28.75
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
26.63 | 2.01B | 1.29B | 67.69M | 184.42M | 0.7701 |
UNH
Unitedhealth Group Inc
|
408.52 | 368.30B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
101.96 | 128.21B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
404.07 | 86.69B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
298.00 | 77.99B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
379.22 | 44.27B | 137.20B | 1.15B | 1.27B | 9.3439 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-12-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-08-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
What Progyny (PGNY)'s Governance Shift And $200 Million Buyback Mean For Shareholders - Yahoo Finance
What Progyny (PGNY)'s Supermajority Rollback and US$200 Million Buyback Mean For Shareholders - simplywall.st
Progyny Inc stock (US74340E1038): fertility benefits specialist after recent share price swings - AD HOC NEWS
Progyny (PGNY) Schedule 13G/A Amendment No.4 — Kleiner Perkins shows 0% ownership - Stock Titan
Progyny CFO Mark Livingston sells $64,183 in company stock By Investing.com - Investing.com South Africa
Progyny EVP Allison Swartz sells $45,021 in company stock By Investing.com - Investing.com South Africa
Progyny (NASDAQ:PGNY) EVP Sells $15,022.92 in Stock - MarketBeat
Allison Swartz Sells 1,199 Shares of Progyny (NASDAQ:PGNY) Stock - MarketBeat
Progyny (NASDAQ:PGNY) CFO Sells $64,183.50 in Stock - MarketBeat
Progyny EVP Allison Swartz sells $45,021 in company stock - Investing.com India
Progyny CFO Mark Livingston sells $64,183 in company stock - Investing.com
Progyny (PGNY) CFO Livingston sells shares in 10b5-1 plan, retains 74,688 - Stock Titan
Progyny (PGNY) EVP Swartz logs small share sales under 10b5-1 plan - Stock Titan
Progyny (PGNY) CEO reports 5,361-share tax withholding, holds 811,472 shares - Stock Titan
PGNY (NASDAQ: PGNY) affiliate files Rule 144 reporting sales and vesting - Stock Titan
Progyny Inc stock (US74340E1038): Canaccord upgrade and insider filings put focus on Nasdaq fertilit - AD HOC NEWS
Progyny (PGNY) Authorizes $200M Share Repurchase Program - Yahoo Finance
Progyny Rises Again as Wall Street Keeps Buying Fertility-Benefits Rebound - Bez Kabli
Allison Swartz (PGNY) reports sales of 599, 2,398 and 1,199 shares - Stock Titan
Conservative Guidance Weighed on Progyny (PGNY) Amid Strong Demand and Solid Execution - Insider Monkey
Progyny (PGNY) CFO logs small share sale and tax withholding moves - Stock Titan
Director at Progyny (NASDAQ: PGNY) exercises options and sells stock - Stock Titan
Progyny (NASDAQ: PGNY) executive exercises options with small share sale - Stock Titan
Allison Swartz (PGNY) files Form 144 to sell 1,199 vested shares (06/03/2026) - Stock Titan
PGNY Maintained by B of A Securities -- Price Target Raised to $31 - GuruFocus
[144] Progyny, Inc. SEC Filing - Stock Titan
Mark Livingston plans sale of 279 PGNY shares (NASDAQ: PGNY) - Stock Titan
Progyny, Inc. Stock 12‑Month Price Target Raised to $29.73, Implies 13% Upside - TradingView
BofA Securities Maintains Progyny(PGNY.US) With Buy Rating, Announces Target Price $31 - Moomoo
Jefferies cuts Progyny stock price target on guidance miss - Investing.com
Progyny (PGNY) EVP, GC Swartz sells shares under Rule 10b5-1 plan - Stock Titan
Director proposes sale of 2,676 shares — PGNY (NASDAQ: PGNY) - Stock Titan
A Progyny (PGNY) Insider Sold 5,500 Shares for $137,000 - Yahoo Finance
(PGNY) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Progyny (PGNY) director Kevin Gordon sells 5,500 shares and shifts holdings to trust - Stock Titan
Progyny Inc. (PGNY) Edges Higher Amid Consolidation Near Key LevelsSuperTrend Flip - newsline.com
symbol__ Stock Quote Price and Forecast - CNN
PGNY (NASDAQ: PGNY) affiliate plans sale of 2,398 shares from vested stock - Stock Titan
New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System - marketscreener.com
Fertility patients say tech alone isn’t enough—they want human support - Stock Titan
Progynyn (NASDAQ:PGNY): A Bull Flag Breakout with Strong Fundamentals - ChartMill
Progyny sets $200M share repurchase program - MSN
Progyny (PGNY) investors back charter and bylaw changes easing supermajority votes - Stock Titan
Fertility benefits growth and share buybacks keep Progyny (PGNY) earnings in focus - MSN
Progyny Announces $200 Million Share Repurchase Authorization - The Globe and Mail
Bull of the day: Progyny (PGNY) - MSN
Progyny (PGNY) director receives RSUs, stock options in lieu of cash - Stock Titan
Progyny (PGNY) grants RSUs and stock options to director Dean Lloyd H - Stock Titan
Progyny (PGNY) director Kevin Gordon awarded RSUs and options in new equity grants - Stock Titan
Progyny (PGNY) director Roger Holstein receives RSUs and stock option awards - Stock Titan
Director at Progyny (NASDAQ: PGNY) receives RSUs and stock options grant - Stock Titan
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.47%
3.66%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):